ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

European shares gain on boost from Novartis, telecom stocks drag
Europe's healthcare sector, up 0.4%, also got a boost from 3.9% gains in shares of Swedish Orphan Biovitrum (SOBI) after the drugmaker's second-quarter earnings beat estimates.
Announcement as on 18 July 2023

: Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a .5 billion deal
Bausch + Lomb Corp. BLCO confirmed that it was buying the “dry eye” treatment Xiidra from Novartis AG NVSCH:NOVN in a deal valued at .5 billion. Under terms of the deal, Bausch + Lomb will make an upfront payment of .75 billion in cash, and could m
Announcement as on 30 June 2023

: Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a .5 billion deal
Bausch + Lomb Corp. BLCO confirmed that it was buying the “dry eye” treatment Xiidra from Novartis AG NVSCH:NOVN in a deal valued at .5 billion. Under terms of the deal, Bausch + Lomb will make an upfront payment of .75 billion in cash, and could m
Announcement as on 30 June 2023

: Chinook Therapeutics stock surges on deal to be bought for up to .5 billion by Novartis
Shares of Chinook Therapeutics KDNY rose 67% to .02 after it agreed to be bought by Novartis NVS for up to .5 billion. Holders of Chinook will receive .2 billion, or per share, in cash upon closing, plus a contingent value right with a value of
Announcement as on 12 June 2023

AVROBIO To Sell Cystinosis Gene Therapy To Novartis For .5 Mln; AVRO Stock Surge In Pre-Market
(RTTNews) - AVROBIO, Inc. (AVRO), a company focused on gene therapy, on Monday announced a deal to sell its investigational hematopoietic stem cell gene therapy program for the treatment of cystinosis, to Novartis AG (NVS) for .5 million in cash.
Announcement as on 22 May 2023

Announcements by Novartis first page | Next page | Prev page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 790.73
  • 12Day Average: 795.29
  • 20Day Average: 804.69
  • 50Day Average: 836.86
  • 100Day Average: 885.76
  • 150Day Average: 925.41
  • 200Day Average: 894.36

500672 Indicators & signals

Indicator MACD (12,26,9)

795.45, 810.63, -15.09
Indicator MACD is in negative zone

Indicator ADX (14)

52.83, 8.42, 27.26
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Tue Dec 2025 772.05 766.25 to 799.85 -2.35% 0.91 times
15 Mon Dec 2025 790.65 788.05 to 808.95 -1.24% 0.58 times
12 Fri Dec 2025 800.55 795.00 to 812.45 0.01% 1.54 times
11 Thu Dec 2025 800.45 790.00 to 809.70 1.33% 0.79 times
10 Wed Dec 2025 789.95 775.15 to 799.05 -0.65% 0.5 times
09 Tue Dec 2025 795.10 778.00 to 799.95 1.53% 0.26 times
08 Mon Dec 2025 783.15 774.90 to 798.80 -0.15% 0.25 times
05 Fri Dec 2025 784.35 780.50 to 801.10 -1.6% 0.61 times
04 Thu Dec 2025 797.10 790.00 to 813.10 -1.48% 5.14 times
03 Wed Dec 2025 809.10 808.20 to 815.00 -0.12% 0.16 times
02 Tue Dec 2025 810.10 808.05 to 816.00 -0.1% 0.16 times
01 Mon Dec 2025 810.95 805.50 to 816.85 0.4% 0.14 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top